Cargando…

Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics

Craniopharyngiomas (CPs) are rare tumors of the sellar and suprasellar regions of embryonic origin. The primary treatment for CPs is surgery but it is often unsuccessful. Although CPs are considered benign tumors, they display a relatively high recurrence rate that might compromise quality of life....

Descripción completa

Detalles Bibliográficos
Autores principales: Martínez-Ortega, Antonio, Flores-Martinez, Álvaro, Venegas-Moreno, Eva, Dios, Elena, Del Can, Diego, Rivas, Eloy, Kaen, Ariel, Cárdenas Ruiz-Valdepeñas, Eugenio, Fajardo, Elena, Roldán, Florinda, González-Rivera, Natividad, Oliva, Rosario, Fernández-Peña, José Ignacio, Soto-Moreno, Alfonso, Cano, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746083/
https://www.ncbi.nlm.nih.gov/pubmed/35012020
http://dx.doi.org/10.3390/jcm11010281
_version_ 1784630499334946816
author Martínez-Ortega, Antonio
Flores-Martinez, Álvaro
Venegas-Moreno, Eva
Dios, Elena
Del Can, Diego
Rivas, Eloy
Kaen, Ariel
Cárdenas Ruiz-Valdepeñas, Eugenio
Fajardo, Elena
Roldán, Florinda
González-Rivera, Natividad
Oliva, Rosario
Fernández-Peña, José Ignacio
Soto-Moreno, Alfonso
Cano, David A.
author_facet Martínez-Ortega, Antonio
Flores-Martinez, Álvaro
Venegas-Moreno, Eva
Dios, Elena
Del Can, Diego
Rivas, Eloy
Kaen, Ariel
Cárdenas Ruiz-Valdepeñas, Eugenio
Fajardo, Elena
Roldán, Florinda
González-Rivera, Natividad
Oliva, Rosario
Fernández-Peña, José Ignacio
Soto-Moreno, Alfonso
Cano, David A.
author_sort Martínez-Ortega, Antonio
collection PubMed
description Craniopharyngiomas (CPs) are rare tumors of the sellar and suprasellar regions of embryonic origin. The primary treatment for CPs is surgery but it is often unsuccessful. Although CPs are considered benign tumors, they display a relatively high recurrence rate that might compromise quality of life. Previous studies have reported that CPs express sex hormone receptors, including estrogen and progesterone receptors. Here, we systematically analyzed estrogen receptor α (ERα) and progesterone receptor (PR) expression by immunohistochemistry in a well-characterized series of patients with CP (n = 41) and analyzed their potential association with tumor aggressiveness features. A substantial proportion of CPs displayed a marked expression of PR. However, most CPs expressed low levels of ERα. No major association between PR and ERα expression and clinical aggressiveness features was observed in CPs. Additionally, in our series, β-catenin accumulation was not related to tumor recurrence.
format Online
Article
Text
id pubmed-8746083
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-87460832022-01-11 Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics Martínez-Ortega, Antonio Flores-Martinez, Álvaro Venegas-Moreno, Eva Dios, Elena Del Can, Diego Rivas, Eloy Kaen, Ariel Cárdenas Ruiz-Valdepeñas, Eugenio Fajardo, Elena Roldán, Florinda González-Rivera, Natividad Oliva, Rosario Fernández-Peña, José Ignacio Soto-Moreno, Alfonso Cano, David A. J Clin Med Article Craniopharyngiomas (CPs) are rare tumors of the sellar and suprasellar regions of embryonic origin. The primary treatment for CPs is surgery but it is often unsuccessful. Although CPs are considered benign tumors, they display a relatively high recurrence rate that might compromise quality of life. Previous studies have reported that CPs express sex hormone receptors, including estrogen and progesterone receptors. Here, we systematically analyzed estrogen receptor α (ERα) and progesterone receptor (PR) expression by immunohistochemistry in a well-characterized series of patients with CP (n = 41) and analyzed their potential association with tumor aggressiveness features. A substantial proportion of CPs displayed a marked expression of PR. However, most CPs expressed low levels of ERα. No major association between PR and ERα expression and clinical aggressiveness features was observed in CPs. Additionally, in our series, β-catenin accumulation was not related to tumor recurrence. MDPI 2022-01-05 /pmc/articles/PMC8746083/ /pubmed/35012020 http://dx.doi.org/10.3390/jcm11010281 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Martínez-Ortega, Antonio
Flores-Martinez, Álvaro
Venegas-Moreno, Eva
Dios, Elena
Del Can, Diego
Rivas, Eloy
Kaen, Ariel
Cárdenas Ruiz-Valdepeñas, Eugenio
Fajardo, Elena
Roldán, Florinda
González-Rivera, Natividad
Oliva, Rosario
Fernández-Peña, José Ignacio
Soto-Moreno, Alfonso
Cano, David A.
Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics
title Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics
title_full Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics
title_fullStr Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics
title_full_unstemmed Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics
title_short Sex Hormone Receptor Expression in Craniopharyngiomas and Association with Tumor Aggressiveness Characteristics
title_sort sex hormone receptor expression in craniopharyngiomas and association with tumor aggressiveness characteristics
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746083/
https://www.ncbi.nlm.nih.gov/pubmed/35012020
http://dx.doi.org/10.3390/jcm11010281
work_keys_str_mv AT martinezortegaantonio sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics
AT floresmartinezalvaro sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics
AT venegasmorenoeva sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics
AT dioselena sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics
AT delcandiego sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics
AT rivaseloy sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics
AT kaenariel sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics
AT cardenasruizvaldepenaseugenio sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics
AT fajardoelena sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics
AT roldanflorinda sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics
AT gonzalezriveranatividad sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics
AT olivarosario sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics
AT fernandezpenajoseignacio sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics
AT sotomorenoalfonso sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics
AT canodavida sexhormonereceptorexpressionincraniopharyngiomasandassociationwithtumoraggressivenesscharacteristics